[Diagnosis and treatment of postmenopausal osteoporosis].
Mizunuma
Hideki
H
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine.
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001862:Bone Resorption; D002116:Calcitonin / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000172:deficiency / Q000502:physiology; D005260:Female; D006801:Humans; D010006:Osteoblasts / Q000502:physiology; D010010:Osteoclasts / Q000502:physiology; D010012:Osteogenesis; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D053245:RANK Ligand / Q000502:physiology; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D014807:Vitamin D / Q000627:therapeutic use*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D004967:Estrogens; D053245:RANK Ligand; D020845:Selective Estrogen Receptor Modulators; D014807:Vitamin D; D002116:Calcitonin